Details for New Drug Application (NDA): 213219
✉ Email this page to a colleague
NDA 213219 describes CLOMIPRAMINE HYDROCHLORIDE, which is a drug marketed by Ajanta Pharma Ltd, Alembic, Amneal Pharms Co, Aurobindo Pharma, Chartwell Rx, Ixora Lifescience, Jubilant Cadista, Lupin Ltd, Mankind Pharma, Micro Labs, Pharmobedient, Rk Pharma, Sandoz, Taro, Teva, Tp Anda Holdings, Unique, Watson Labs, and Zydus Pharms, and is included in twenty-one NDAs. It is available from eighteen suppliers. Additional details are available on the CLOMIPRAMINE HYDROCHLORIDE profile page.
The generic ingredient in CLOMIPRAMINE HYDROCHLORIDE is clomipramine hydrochloride. There are eleven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the clomipramine hydrochloride profile page.
The generic ingredient in CLOMIPRAMINE HYDROCHLORIDE is clomipramine hydrochloride. There are eleven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the clomipramine hydrochloride profile page.
Summary for 213219
| Tradename: | CLOMIPRAMINE HYDROCHLORIDE |
| Applicant: | Micro Labs |
| Ingredient: | clomipramine hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 213219
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLOMIPRAMINE HYDROCHLORIDE | clomipramine hydrochloride | CAPSULE;ORAL | 213219 | ANDA | Micro Labs Limited | 42571-342 | 42571-342-01 | 100 CAPSULE in 1 BOTTLE (42571-342-01) |
| CLOMIPRAMINE HYDROCHLORIDE | clomipramine hydrochloride | CAPSULE;ORAL | 213219 | ANDA | Micro Labs Limited | 42571-342 | 42571-342-05 | 500 CAPSULE in 1 BOTTLE (42571-342-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
| Approval Date: | Jun 22, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
| Approval Date: | Jun 22, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 75MG | ||||
| Approval Date: | Jun 22, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
